425: Strive, Semler Scientific Merger: Risks & Outlook

Strive, Inc. and Semler Scientific, Inc. issued a communication regarding their proposed business combination, highlighting forward-looking statements and associated risks.

Summary

• The communication was reposted on X.com by Pierre Rochard, Board Member of Strive, Inc., on October 24, 2025.
• It pertains to Strive's proposed business combination with Semler Scientific, Inc.
• The filing includes a cautionary statement regarding forward-looking statements, outlining inherent risks and uncertainties.
• It details the process for obtaining additional information, including the upcoming Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus.
• The communication explicitly states it is not an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement for a proposed merger, heavily emphasizing risks and uncertainties, which balances any implied positive sentiment from the merger itself.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected to be realized from the business combination.

Negatives

• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Dilution is possible due to Strive's issuance of additional shares of its Class A common stock in connection with the transaction.
• Potential for adverse reactions from customers or changes to business or employee relationships exists.
• Changes in Strive's or Semler Scientific's share price before closing are a possibility.

Risks

• The occurrence of any event, change, or other circumstance could give rise to the right of one or both companies to terminate the merger agreement.
• The proposed transaction may not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company is uncertain.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks are associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the combined company.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities is a risk.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Strive and Semler Scientific anticipate strategic and financial benefits from the proposed transaction, including expected impact on the combined company's future financial performance, cost savings, and strategic gains. However, these forward-looking statements are based on assumptions and are subject to significant risks, uncertainties, and other factors that could cause actual results to differ materially.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Customers of Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Business and employee relationships may change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury, Digital Assets